Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |3 March 2009

Response to Cholesterol-Lowering Drugs in Patients With and Without HIV Infection

  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the researchers do this particular study?
    • Who was studied?
    • How was the study done?
    • What did the researchers find?
    • What were the limitations of the study?
    • What are the implications of the study?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link
  • CiteULike Link

What is the problem and what is known about it so far?

Human immunodeficiency virus (HIV) causes AIDS. The body's ability to fight off infections and certain types of cancer. Treatments, especially those that include protease inhibitors or non-nucleoside reverse transcriptase inhibitors (NNRTIs), have greatly improved outcomes for patients with HIV infection. Cholesterol problems can be side effects of HIV treatments. We do not know whether cholesterol problems are harder to treat in HIV-infected patients than in uninfected patients.

Why did the researchers do this particular study?

To compare the effectiveness and side effects of drugs to treat cholesterol problems in patients with and without HIV infection.

Who was studied?

829 patients with HIV infection and 6941 patients without HIV infection.

How was the study done?

The researchers compared changes in patients' levels of low-density lipoprotein (LDL) cholesterol (bad cholesterol) and triglycerides (another bad fat) after the start of cholesterol treatment. They also looked at whether the cholesterol changes in HIV-infected patients were related to the types of HIV treatments that they were taking.

What did the researchers find?

Patients with HIV infection who started cholesterol treatments had smaller changes in LDL cholesterol than patients without HIV infection; this did not vary with type of HIV treatment. High triglyceride levels were more difficult to treat in HIV-infected patients than in uninfected patients, and the difficulty varied with the type of HIV treatment. Patients receiving regimens containing both protease inhibitors and NNRTIs had the smallest changes in triglyceride levels, followed by patients receiving protease inhibitors only. However, HIV-infected patients who were receiving NNRTIs only and the cholesterol-lowering drug gemfibrozil had decreases in triglyceride levels similar to those in uninfected patients receiving gemfibrozil. Side effects of cholesterol treatments occurred in very few patients, but HIV-infected patients had more changes in liver and muscle enzyme levels than uninfected patients.

What were the limitations of the study?

This study included only patients with health insurance, most of the patients were men, and not all patients had cholesterol measured at the same time points.

What are the implications of the study?

Cholesterol problems seem to be more difficult to treat in HIV-infected patients than in uninfected patients. The benefits in terms of LDL cholesterol and triglyceride levels are smaller in HIV-infected patients than in uninfected patients receiving the same drugs. Gemfibrozil seems to be a good choice for treating high triglyceride levels in HIV-infected patients who are taking NNRTIs. Side effects of cholesterol treatments occur in very few patients.

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Response to Cholesterol-Lowering Drugs in Patients With and Without HIV Infection. Ann Intern Med. 2009;150:I–38. doi: 10.7326/0003-4819-150-5-200903030-00003

Download citation file:

  • RIS (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2018

×
Permissions

Published: Ann Intern Med. 2009;150(5):I-38.

DOI: 10.7326/0003-4819-150-5-200903030-00003

0 Citations

See Also

Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
View MoreView Less

Related Articles

HIV Incidence, HIV Prevalence, and Undiagnosed HIV Infections in Men Who Have Sex With Men, United States
Annals of Internal Medicine; ():
Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012
Annals of Internal Medicine; 168 (4): 245-254
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial
Annals of Internal Medicine; 167 (6): 384-393
Annals for Educators - 19 September 2017
Annals of Internal Medicine; 167 (6): ED6
View MoreView Less

Journal Club

TDF-FTC before and after sex reduced HIV infection but increased GI, renal events in men who have sex with men
Annals of Internal Medicine; 164 (6): JC28
Preexposure tenofovir–emtricitabine reduced HIV infection in men who have unprotected anal sex with men
Annals of Internal Medicine; 164 (2): JC3
In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years
Annals of Internal Medicine; 163 (12): JC4
Prophylactic tenofovir reduced HIV infection in injectable drug users
Annals of Internal Medicine; 159 (6): JC8
View MoreView Less

Related Point of Care

Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 167 (1): ITC1-ITC16
Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 155 (7): ITC4-1
View MoreView Less

Related Topics

HIV
Infectious Disease

HIV, Infectious Disease.

PubMed Articles

Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection.
Immunity 2018;48(4):730-744.e5.
Coccidioidomycosis in selected immunosuppressed hosts.
Med Mycol 2018.
View More

Results provided by: PubMed

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Online First RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards

  • Personae Photography Prize
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×